Introduction
============

Ischemic stroke accounts for about 80 % of the stroke population[@R1] and is a leading cause of mortality, presents a serious threat to public health[@R2],[@R3]. Most strokes occur in people older than 70 years, rarely occuring in those below 35 years old[@R4],[@R5]. Ischemic stroke is a multi-factorial disorder[@R6]. A number of risk factors are associated with an increased risk of stroke. They can be stratified into modifiable and non-modifiable risk factors. It is widely accepted that stroke increases dramatically with age and it is more likely to affect the elderly. Ischemic stroke is no longer a disease affecting just elderly people, one-fourth of ischemic strokes occurs in working-aged individuals and an estimated 3.6 million young people are affected each year. Approximately 10% of ischemic strokes occur in people aged less than 50 years[@R7],[@R8]. Ischemic stroke at young age may be increasing further, since multiple recent studies have reported increasing incidence of ischemic strokes particularly at younger ages since 1980s, while incidence at older ages has been declining during the same period[@R9]--[@R13]. Higher stroke rates are noted in African Americans, Hispanic Americans and the Black race compared to the White one. In addition to common risk factors such as hypertension, diabetes, and smoking, recent studies have shown that genetic factors have important roles in the pathogenesis of ischemic stroke[@R14],[@R15]. Higher prevalence of stroke is noted in Chinese and Japanese population[@R4],[@R5]. Thus identification and management of possible risk factors to prevent stroke is an important strategy to reduce human and economic burden of ischemic stroke[@R5].

This review discusses and summarizes the evidence for modifiable and non-modifiable risk factors in ischemic stroke and their association on Asian population.

Methodology
===========

Data identification and extraction
----------------------------------

We searched the PubMed, Google, MEDLINE, CNKI, VIP INFORMATION and Embase databases were searched up to April 2018 using ischemic stroke to identify all relevant literature on human studies. Furthermore, we searched the reference lists of reviews and retrieved articles manually. When the same patient population appeared in several publications, we chose the largest sample size. Data from each eligible study was extracted such as year of publication, first author name, ethnicity/country, number of ischemic stroke patients and healthy controls, modifiable and non-modifiable risk factors and reported associations. This meta-analysis included a total of 08 articles on modifiable and non-modifiable risk factors and ischemic stroke. Data were extracted independently from each study by using a pre-defined form and disagreements were resolved by discussion.

Inclusion criteria
------------------

The selected studies met the following criteria: well-designed case-control studies to evaluate the modifiable and non-modifiable factors and ischemic stroke risk.

Exclusion criteria
------------------

Studies were excluded if one of the following existed: non-Asian population; animal studies, reviews, case reports, abstracts and family-based studies.

Statistical analysis
--------------------

Comprehensive meta-analysis (CMA) V.3 was employed for calculation of pooled standard errors and 95% confidence interval (CIs). The standard differences in means were estimated for each study in a random-effect model. A chi-square-based Q test was used to measure between-study heterogeneity. Statistical significance was defined at P \< 0.01. In addition, I2 statistic was calculated to quantify the proportion of the total variation across studies due to heterogeneity (I2 = 0%--25%: no heterogeneity; I2= 25--50%: moderate heterogeneity; I2=50--75%: large heterogeneity; I2= 75--100%: extreme heterogeneity)[@R16]. The ORs were pooled using the fixed effects model (Mantel-Haenszel method)[@R17] when P\>0.01 and the random effects model (Der Simonian and Laird method)[@R18] if P\<0.01. Meta-analysis of the present studies yielded I2 values of \>95%, thus indicate significant heterogeneity. Subgroup analysis by ethnicity and sample size (500--1000 \<500\> 1000) were performed to further identify heterogeneity.

Results
=======

Study characteristics
---------------------

A total of sixty-five papers were obtained by the publication search, among which eight met the inclusion criteria all in English ([Fig 1](#F1){ref-type="fig"}). Eight meta-analyzed studies conducted in different parts of the world comparing modifiable and non-modifiable risk factors in ischemic stroke patients and healthy controls. After detailed evaluation of titles, abstracts and careful study of papers/articles, 08 eligible articles were screened for the meta-analysis, including 2611 confirmed ischemic stroke patients and 2833 healthy controls. The characteristics of the selected studies of cases and controls are shown in [Table 1](#T1){ref-type="table"}. The Q test and I2 statistics revealed heterogeneity among the included studies and thus a random-effects model was employed in analysis of all the modifiable and non-modifiable risk factors. Hence following risk factors were evaluated in ischemic patients and healthy controls to find out the overall association of the risk factors with ischemic patients.
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###### 

The main characteristics of studies selected for meta-analysis and distribution of modifiable and non-modifiable risk factors in Ischemic stroke patients and healthy controls

  ------------------------------------------------------------------------------------------------------------------------------------------------------
                      Ischemic stroke   Healthy control                                                                                         
  ------------------- ----------------- ----------------- -------- -------- ------- ------- -------- ------- -------- -------- ------- -------- --------
  ZHONG et al.\       China             65.49             4.4      1.76     1.24    2.45    \-       67.12   5.18     1.57     1.18    2.66     \-
  (2017)\                                                                                                                                       
  (300/300)                                                                                                                                     

  Ming-Song et al.\   Taiwan            70                187.14   141.32   41.06   117.9   119.43   63      183.28   105.39   42.63   124.55   109.81
  (2009)\                                                                                                                                       
  (100/270)                                                                                                                                     

  Minjie Shao et\     China             68.56             4.73     1.79             2.91    \-       63.82   4.86     1.79             3.03     \-
  al. (2013)\                                                                                                                                   
  (459/462)                                                                                                                                     

  Wu et al. (2017)\   Mongolia          57.5              5.11     2.13     1.39    3.08    \-       50.99   7.97     2.24     1.45    3.08     \-
  (167/176)                                                                                                                                     

  Hua-Tuo et al.\     China             60.7              5.29     2.09     1.31    2.98    \-       63.9    4.86     1.54     1.69    2.31     \-
  (2017)\                                                                                                                                       
  (380/450)                                                                                                                                     

  Hong Li et al.\     China             62.3              5.35     1.89     1.35    3.08    6.25     69.01   5.4      1.62     1.48    2.85     5.93
  (2017)\                                                                                                                                       
  (385/362)                                                                                                                                     

  Satrupa et al.\     India             51.3              194.2    173.4    49.5            135.7    49.08   195.8    138.2    59.3    \-       119.4
  (2018)\                                                                                                                                       
  (620/620)                                                                                                                                     

  Murali et al.\      India             57.5              207.8    195.4    43.7    130     154.1    56      170.4    150.9    37.2    97.4     106.2
  (2014)\                                                                                                                                       
  (200/193)                                                                                                                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------

Mean values

HDL-C=high density lipid-cholesterol

LDL-C= low density lipid-cholesterol

Age=Years

Total Cholesterol, Triglyceride, HDL-C, LDL-C= mmol/l

Glucose =mg/dl

Triglyceride
------------

The levels of triglyceride were evaluated in 2611 confirmed ischemic stroke patients and 2833 controls. Overall data revealed significant heterogeneity Q=160, I2=95.62%, P=0.00 shown in [Table 2](#T2){ref-type="table"}. Meta-analysis by Random- effects model showed significant association of triglyceride with ischemic stroke with pooled standard error= 0.13 (−0.62-(−0.09), Z=-2.65, P=0.007 as shown in [Fig 2](#F2){ref-type="fig"}.

###### 

Statistics to test publication bias and heterogeneity in the meta-analysis

  ---------------------------------------------------------------------------------------------------------------------------------
  Number\      Genotype\            Effect size and 95% interval   Heterogeneity analysis                                   
  of studies   (Case/Control)                                                                                               
  ------------ -------------------- ------------------------------ ------------------------ ------- ------- -------- ------ -------
  08           Age\                 0.15                           (−0.36--0.25)            −0.34   0.72    218.04   0.00   96.78
               (2611/2833)                                                                                                  

  08           Total Cholesterol\   0.13                           (−0.27--0.24)            −0.09   0.92    154.47   0.00   95.46
               (2611/2833)                                                                                                  

  08           Triglyceride\        0.13                           (−0.62-(−0.09)           −2.65   0.008   160.00   0.00   95.62
               (2611/2833)                                                                                                  

  07           HDL-C\               0.18                           (−0.20--0.53)            0.85    0.39    219.12   0.00   97.26
               (2152/2371)                                                                                                  

  07           LDL-C\               0.15                           (−0.44--0.14)            −1.00   0.31    134.30   0.00   95.53
               (1991/2213)                                                                                                  

  04           Glucose\             0.23                           (−1.08-(−0.14)           −2.56   0.01    96.33    0.00   96.88
               (1305/1445)                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------

CI=confidence interval; Chi^2^ Q-statistic for homogeneity in Random-effects model

P-value for the Q-statistic in random-effect model

Higgins I^2^-statistic for heterogeneity in random-effect model

HDL-C=high density lipid-cholesterol

LDL-C= low density lipid-cholesterol

Age=Years

Total Cholesterol, Triglyceride, HDL-C, LDL-C= mmol/l

Glucose =mg/dl
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Total Cholesterol
-----------------

Total cholesterol was analyzed in 2611 ischemic stroke patients and 2833 controls and a significant heterogeneity was observed with Q=154.47, I2=95.46%, P=0.00 shown in [Table 2](#T2){ref-type="table"}. Meta-analysis of the above mentioned samples showed non-significant association of total cholesterol with ischemic stroke having pooled standard error= 0.13 (−0.27--0.24), Z=-0.09, P=0.92 shown in [Fig 2](#F2){ref-type="fig"}.

High density lipid-cholesterol (HDL-C)
--------------------------------------

Ratio of ischemic stroke patients andcontrols with respect to high density lipid-cholesterol (HDL-C) was 2152/2371. There was significant heterogeneity with Q=219.12, I2=97.26%, P=0.00 shown in [Table 2](#T2){ref-type="table"}. Meta-analysis of the high density lipid-cholesterol (HDL-C) levels between ischemic stroke patients and healthy controls showed non-significant results with pooled standard error=0.18 (−0.20--0.53), Z=0.85, P=0.39 shown in [Fig 3](#F3){ref-type="fig"}.

![Forest plots showing effect of High Density Lipid- Cholesterol (HDL-C) and Low Density Lipid- Cholesterol (LDL-C) on ischemic stroke.](AFHS1902-2121Fig3){#F3}

Low density lipid-cholesterol (LDL-C)
-------------------------------------

Ratio of ischemic stroke patients and controls with respect to low density lipid-cholesterol (LDL-C) was 1991/2213. There was significant heterogeneity with Q=134.30, I2=95.53%, P=0.00 shown in [Table 2](#T2){ref-type="table"}. Meta-analysis of low density lipid-cholesterol (LDL-C) levels between ischemic stroke patients and healthy controls showed non-significant results with pooled standard error =0.15 (−0.44--0.14), Z=-1.00, P=0.31 as shown [Fig 3](#F3){ref-type="fig"}.

Glucose
-------

Ratio of ischemic stroke patients and controls were 1305/1445. There was significant heterogeneity Q=96.33, I2=96.88%, P=0.00 shown in [Table 2](#T2){ref-type="table"}. Meta-analysis of glucose levels between ischemic stroke patients and healthy controls showed significant results with pooled standard error =0.23 (-1.08- (−0.14), Z=-2.56, P=0.01 as shown in [Fig 4](#F4){ref-type="fig"}.
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Age
---

2611 ischemic stroke patients and 2833 controls with respect to age were analyzed for heterogeneity and significant heterogeneity among studies was observed with Q=218.04, I2=96.78%, P=0.00 as indicated in [Table 2](#T2){ref-type="table"}. Meta-analysis of the age in all cases and controls revealed non-significant results with pooled standard error=0. 15 (−0.36--0.25), Z= −0.34, P=0.72 as shown in [Fig 4](#F4){ref-type="fig"}.

Discussion
==========

This present meta-analysis was undertaken to ascertain the role of modifiable and non-modifiable risk factors on ischemic stroke in Asian population. Therefore relevant data was searched on ischemic stroke viz-a-viz modifiable and non-modifiable risk factors. By comparing the results published before and in the present study, we found great interest in the present meta-analysis.

In a systematic review of cohort studies with ischemic stroke sub-type specific follow-up data on death and recurrent stroke[@R19] the risk of a lacunar recurrence following a lacunar event at baseline was twice as great as the risk of lacunar recurrence following a non-lacunar event at baseline. Hypertension and diabetes were significant factors associated with recurrent lacunes, whereas hyperlipidaemia had a protective role. Recurrent lacunar infarction, especially in the case of multiple episodes of recurrent lacunes, may alert to the presence of cognitive impairment[@R20].

Ischemic stroke is a clinical syndrome with various genetic and clinical risk factors including age, cholesterol, triglyceride, HDL-C, LDL-C and glucose. Case-control studies are commonly used to find the association between the risk factors and the complex human diseases. A recent meta-analysis suggests that the association of lipoprotein (a) and ischemic stroke is stronger for young adults aged \<55 years than for older individuals[@R21]. A Dutch study showed a fourfold higher mortality for young patients with ischemic stroke compared to age and sex matched background population, with excess mortality present across all age groups, but particularly for those aged 35--50 years[@R22]. The best UK data on stroke project shows incidence rate for first stroke is 1.6 per 1000 person years[@R23].

The presence of sleep apnea is also a risk factor for stroke. Sleep apnea may increase the risk of stroke by leading to or worsening hypertension or ischemic heart disease. Asymptomatic vascular disorders may be viewed as subclinical arterial markers related to cardiovascular risk factors, and are predictors of stroke, myocardial infarction and vascular death in the mid- and long-term.[@R24]

This meta-analysis examined all the available studies on the association between modifiable and non-modifiable risk factors and ischemic stroke risk, including a total of 2611 ischemic patients and 2833 healthy control subjects. Although the pooled results showed that age, total cholesterol, HDL-C and LDL-C were not associated with the risk of ischemic stroke, the trend to an increased risk of developing ischemic stroke was observed due to high glucose (P=0.01) and triglyceride levels (P=0.008). Regarding cholesterol and its components, an association between low high-density lipoprotein cholesterol and ischemic stroke at young age has been demonstrated 25--27 but no clear association has been shown for total cholesterol, low-density lipoprotein cholesterol, or triglycerides. However, we could draw an interesting conclusion from that the more studies were included; the higher risk of developing ischemic stroke was indicated in the results. The overall heterogeneity between studies was very high for ischemic stroke risk factors like age, total cholesterol, triglyceride, HDL-C, LDL-C and glucose levels as indicated by I2 value of \>95% and as such no publication bias was detected within studies included in the meta-analysis.

This meta-analysis had some limitations. First, that only eight papers were included and also confounders were not included in the analysis, even though we tried to find as many studies as we could, assessed the literature carefully and used statistical methods to minimize the publication bias. Second, the number of subjects involved in our meta-analysis was limited. Thus, studies with larger sample size and high quality are needed to demonstrate our conclusions in future.

Conclusion
==========

Meta-analysis of modifiable and non-modifiable risk factors like total cholesterol, high density lipid-cholesterol (HDL-C), low density lipid-cholesterol (LDL-C) and age were not independent risk factors for ischemic stroke; however triglyceride and glucose levels were proved as risk factors for ischemic stroke. Therefore present meta-analysis identified the importance of modifiable risk factors on ischemic stroke predisposition in Asian population.
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